Probiotic manufacturer Blis Technologies is finally seeing the fruits of its labour, reporting a maiden profit of $400,000 as it establishes itself in the Australian market almost 19 years since it was founded
AFT Pharmaceuticals reports a strong rise in operating earnings as it benefits from growth in its main over-the-counter medicine portfolio and the successful conclusion of clinical trials on the key Maxigesic pain relief products
More than one million doses of seasonal influenza vaccine have now been distributed and The Ministry of Health is encouraging even more New Zealanders to get vaccinated.
An overhaul of PHARMAC’s decision-making process will give better insight into what medicines are - and are not - being actively considered for funding, Chief Executive, Sarah Fitt says.
A review and update of the standard batch sheets for oral liquid formulations compounded in New Zealand (NZ standard oral formulations or NZSOF) has been completed.
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes